The way property values are displayed:
The way concept relations are shown:
The way concept relations are shown:
Heparin, Low-Molecular-Weight
Hierarchy: | |
Broader terms: | ∟ ∟ ∟ ∟ ∟ Heparin, Low-Molecular-Weight |
Narrower terms: | |
Annotation: | /antag = probably HEPARIN ANTAGONISTS; DF: note short X ref
X |
History note: | Heparin (1966-1987)X |
historyNote*: | 94; was ENOXAPARIN 1992-93, was HEPARIN, LOW MOLECULAR WEIGHT 1988-91; HEPARIN, LOW MOLECULAR WEIGHT was see ENOXAPARIN 1992-93; LOW-MOLECULAR-WEIGHT HEPARIN was LOW MOLECULAR WEIGHT HEPARIN 1988-93
X |
onlineNote*: | use HEPARIN, LOW-MOLECULAR-WEIGHT to search ENOXAPARIN 1990-93 & HEPARIN, LOW MOLECULAR WEIGHT 1988-93
X |
publicMeSHNote*: | 94; was ENOXAPARIN 1992-93, was HEPARIN, LOW MOLECULAR WEIGHT 1988-91; HEPARIN, LOW MOLECULAR WEIGHT was see ENOXAPARIN 1992-93; LOW-MOLECULAR-WEIGHT HEPARIN was LOW MOLECULAR WEIGHT HEPARIN 1988-93
X |
Scope note: | Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism.
X |
activeMeSHYear*: | |
dateCreated*: | 1987-03-25X |
dateEstablished*: | 1988-01-01X |
dateRevised*: | 2004-07-07X |
recordAuthorizer*: | sjnX |
recordMaintainer*: | ssbX |
recordOriginator*: | RLSX |
Type: | |
Coordinate terms: | |
URI: | |
Labels and equivalent concepts: | Pienimolekyylinen hepariini (fi) XLyhytketjuhepariini (fi, replaced) Pienimolekyyliset hepariinit (fi, replaced) LMWH (fi, replaced) LMW-hepariinit (fi, replaced) LMW-hepariini (fi, replaced) Heparin, lågmolekylärt (sv) Lågmolekylärt heparin (sv, replaced) Low Molecular Weight Heparin (en, replaced) Low-Molecular-Weight Heparin (en, replaced) LMWH (en, replaced) |
Share: |
Loading results...